Edap Tms (NASDAQ:EDAP – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a note issued to investors on Friday,Benzinga reports. They presently have a $19.00 price target on the medical equipment provider’s stock. HC Wainwright also issued estimates for Edap Tms’ FY2029 earnings at $0.40 EPS.
Separately, StockNews.com assumed coverage on Edap Tms in a report on Friday. They issued a “hold” rating for the company.
Get Our Latest Research Report on EDAP
Edap Tms Stock Down 3.2 %
Edap Tms (NASDAQ:EDAP – Get Free Report) last released its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.06. The business had revenue of $22.69 million for the quarter, compared to analyst estimates of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. On average, equities analysts anticipate that Edap Tms will post -0.6 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Edap Tms
A number of large investors have recently made changes to their positions in EDAP. Millennium Management LLC lifted its position in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 33,558 shares during the period. BNP Paribas Financial Markets raised its stake in shares of Edap Tms by 111.5% in the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 25,650 shares during the last quarter. Jane Street Group LLC lifted its holdings in shares of Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73,361 shares during the period. Schonfeld Strategic Advisors LLC boosted its position in Edap Tms by 48.5% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after buying an additional 52,500 shares during the last quarter. Finally, Rock Springs Capital Management LP increased its holdings in Edap Tms by 1.5% in the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock worth $3,518,000 after buying an additional 23,800 shares during the period. 62.74% of the stock is owned by hedge funds and other institutional investors.
Edap Tms Company Profile
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Featured Stories
- Five stocks we like better than Edap Tms
- Most active stocks: Dollar volume vs share volume
- MarketBeat Week in Review – 03/24 – 03/28
- Golden Cross Stocks: Pattern, Examples and Charts
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Best Stocks Under $10.00
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.